Packaged Foods and Meats

Bailong Chuangyuan

Bailong Chuangyuan released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 392.61 M, actual EPS CNY 0.29

Bailong Chuangyuan to Release FY2026 Q1 Earnings on April 30 After-Market (BJT)

Bailong Chuangyuan to release FY2025 earnings on April 8, Pre-Market BJT, forecast revenue CNY 1.429 B, EPS CNY 0.8319

Bailong Chuangyuan released FY2025 Annual Earnings on January 22 Pre-Market (BJT), Actual Revenue: CNY 1.379 B (Forecast: CNY 1.429 B), Actual EPS: CNY 0.88 (Forecast: CNY 0.8319)

Bailong Chuangyuan released FY2025 Q4 earnings on January 22 Pre-Market (BJT), actual revenue CNY 410.16 M, actual EPS CNY 0.2503

Bailong Chuangyuan released FY2025 Q3 earnings on October 29 Pre-Market (BJT), actual revenue CNY 319.71 M, actual EPS CNY 0.2306

Bailong Chuangyuan released FY2025 9 Months Earnings on October 29 Pre-Market (BJT), actual revenue CNY 968.9 M, actual EPS CNY 0.6306

Bailong Chuangyuan to Release FY2025 Q3 Earnings on October 30 Pre-Market BJT

Bailong Chuangyuan to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Bailongchuangyuan Awarded Corporate Governance Pioneer Award

Bio-long Creative Park Announces 42.68% YOY Growth in Net Profit for H1 2025

Bailong Chuangyuan released FY2025 Semi-Annual Earnings on July 13 During-Market (BJT), actual revenue CNY 649.19 M, actual EPS CNY 0.4

Bailong Chuangyuan released FY2025 Q2 earnings on July 13 During-Market (BJT), actual revenue CNY 336.46 M, actual EPS CNY 0.2181

Bailongchuangyuan Achieves Industrialization of Allulose and Applies for Multiple Patents

China Yin Securities Gives Buy Rating to Bailong Chuangyuan

Shares of Bilong Chuangyuan Drop After Shareholder Sale

Bailong Chuangyuan Engaged in Block Trades and Shareholder Reduced Holdings

Bio-long Chunyuan Engaged in Block Trades

Shares in Bio-long Biochem Park Traded in Block Trades with Shareholders Cutting Holdings

China Yin Securities Gives Buy Rating to Bailongchuangyuan

605016

Bailong Chuangyuan announced that the revenue for the third quarter was 320 million yuan, a year-on-year increase of 10.61%; the net profit was 94.8441 million yuan, a year-on-year increase of 50.48%. The revenue for the first three quarters was 969 million yuan, a year-on-year increase of 18.10%; the net profit was 265 million yuan, a year-on-year increase of 44.93%

Zhitong

Bailong Chuangyuan: The net profit for the third quarter was 94.8441 million yuan, a year-on-year increase of 50.48%

Bailong Chuangyuan released its third-quarter performance report, with a net profit attributable to the parent company of 265 million yuan for the first three quarters of 2023, a year-on-year increase of 44.93%. The total operating revenue was 969 million yuan, a year-on-year increase of 18.10%. The main reasons for the growth include product structure optimization, capacity release, and equity distribution leading to an increase in total share capital

In the first three quarters, Bailong Chuangyuan's net profit attributable to the parent company was 265 million yuan, a year-on-year increase of 44.93%

According to the Zhitong Finance APP, Bailong Chuangyuan disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 649 million yuan, a year-on-year increase of 22.18%; net profit attributable to the parent company was 170 million yuan, a year-on-year increase of 42%; net profit excluding non-recurring gains and losses was 167 million yuan, a year-on-year increase of 50.08%; basic earnings per share were 0.40 yuan. The company plans to distribute a cash dividend of 0.5 yuan (tax included) for every 10 shares

Bailong Chuangyuan released its semi-annual performance, with a net profit attributable to the parent company of 170 million yuan, a year-on-year increase of 42%

002286

605077

600500

Sugar substitute concept stocks fluctuated and rose, SINOCHEM INTERNATIONAL hit the daily limit, BLB rose over 5%, HUAKANG, Bailong Chuangyuan, and Xinghuo Technology followed suit

HUAKANG

SINOCHEM INTERNATIONAL

Sugar substitute concept stocks fluctuate and rise, SINOCHEM INTERNATIONAL hits the daily limit

601066

06066

Bailong Chuangyuan announced that its controlling shareholder's concerted actor, Dou Guangpeng, pledged 3.5 million shares, accounting for 34.70% of his holdings and 0.83% of the company's total share capital. The pledge start date is July 22, 2025, and the expiration date is July 22, 2026. The pledgee is CSC, and the purpose of the pledge is for its own production and operation

Bailong Chuangyuan: The concerted actors of the controlling shareholder pledged 0.83% of the company's shares

On the evening of July 13th, Bailong Chuangyuan disclosed its performance report, stating that the total operating revenue for the first half of 2025 was 650 million yuan, a year-on-year increase of 22.29%; the net profit attributable to shareholders of the listed company was 171 million yuan, a year-on-year increase of 42.68%. During the reporting period, the company's production and operations were normal, with domestic and overseas businesses operating normally, achieving a certain degree of growth in both revenue and profit

Bailong Chuangyuan: Net profit in the first half of the year increased by 42.68% year-on-year

On July 3rd, Bailong Chuangyuan stated in a public account that the company has focused its research and development efforts on new generation products such as crystalline allulose since 2014. In 2016, it achieved industrial-scale production of liquid allulose, and in 2019, it overcame technical challenges in crystallization to achieve mass production. It is a participating unit in the preliminary classification of customs import and export tariff codes for allulose. Since 2016, Bailong Chuangyuan has been laying out patents for allulose, and has currently obtained 14 patents, including 8 domestic patents and 6 international PCT patents, covering strains, production processes, and product characteristics

Bailong Chuangyuan: Currently has obtained 14 patents related to allulose

605589

002597

300138

Since the beginning of this year, the overall performance of sugar substitute concept stocks has been strong. According to statistics, as of the close on July 2, the average increase of concept stocks this year is 20.51%, significantly outperforming the Shanghai Composite Index during the same period. Bailong Chuangyuan, Baolingbao, Ruizhi Pharmaceutical, CCGB, and JHSY have all seen cumulative increases of over 40%. In terms of research report ratings, according to Data Treasure statistics, there are 8 concept stocks that have received "positive" ratings from more than 5 institutions, including Sun Paper, SQ Group, Meihua Biological, JHSY, CCGB, and Bailong Chuangyuan

SQ Group

JHSY

CCGB

ChemPartner

MEIHUABIO;Mei Hua Group

SSE Index

SUN PAPER

Jinhe Biotechnology

The overall performance of sugar substitute concept stocks is strong. A list of sugar substitute concept stocks that institutions are paying attention to

As global markets rally, small-cap stocks are navigating modest inflation and mixed economic indicators. Shandong Bailong Chuangyuan Bio-Tech shows impressive earnings growth of 35.3% and is trading below its estimated fair value, indicating potential undervaluation. Dalian Huarui Heavy Industry Group has also demonstrated strong earnings growth of 36.6% and a favorable price-to-earnings ratio. Meanwhile, Beijing SDL Technology has achieved a notable turnaround in profitability with a net income of CNY 10 million. These companies are highlighted as promising small-cap investments with strong fundamentals.

Simplywall

Exploring Shandong Bailong Chuangyuan Bio-Tech And 2 Promising Small Caps In Global Markets

According to the announcement from Bailong Chuangyuan, on June 25, 2025, the company received a "Notice of Share Reduction Results" issued by Qingdao Kaijin and its concerted parties Jiaxing Kaijin and Guo Enyuan. As of June 25, 2025, the time period for this share reduction has expired. During the reduction period, Qingdao Kaijin and its concerted parties Jiaxing Kaijin have cumulatively reduced their holdings in the company by 16.928 million shares, accounting for 4.95% of the company's total share capital

Bailong Chuangyuan: Qingdao Kaijin and its concerted parties have cumulatively reduced their holdings in the company by 4.95%

Bailong Chuangyuan(605016.SH)